|
|
||||||||
|
Interact CardioVasc Thorac Surg 2009;9:199-202. doi:10.1510/icvts.2009.206698 © 2009 European Association of Cardio-Thoracic Surgery
Clinical significance of preoperative carcinoembryonic antigen level for clinical stage I non-small cell lung cancer: can preoperative carcinoembryonic antigen level predict pathological stage?Thoracic Surgery Division, Kyorin University Hospital, 6-20-2 Shinkawa, Mitaka-shi, Tokyo 181-0004, Japan
*Corresponding author. Tel.: +81-3-3542-2511; fax: +81-3-3542-3815.
The purpose of the present study was to retrospectively analyze the clinicopathological characteristics and clarify whether or not the preoperative carcinoembryonic antigen (CEA) level could be used as a decision-making factor as an adjunct to the TNM staging system in patients with clinical stage I non-small cell lung cancer (NSCLC). Between 1993 and 2006, 815 patients who had clinical stage I NSCLC were analyzed retrospectively. The CEA level was defined as being either normal (CEA
Key Words: Lung cancer; Carcinoembryonic antigen; TNM classification
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |